Mirador Global LLC
Fusun Sevgen is a seasoned professional with extensive experience in global commercialization strategy, market access, and pharmaceutical marketing. Currently serving as the VP of Global Commercialization Strategy at Mirador Global LP, specializing in drug commercialization assessment and launch planning in Oncology, CNS, and Orphan Drugs, Fusun has held notable roles such as Senior Director of Global Market Access at The Wharton School, where contributions as a lecturer enhance communication skills for MBA students. Prior experience includes consulting at OxfordSM, where expertise encompassed pharmaceutical strategic marketing and pricing, as well as significant roles at AstraZeneca Pharmaceuticals, including Senior Director of Patient Strategy and Global Pricing & Market Access Director. Educational credentials include an MBA from The Wharton School and a BA Honors/MA in Engineering, Economics & Management from the University of Oxford.
Mirador Global LLC
Mirador Global is a consulting firm providing drug commercialization assessment and launch planning services in Oncology, Immuno-Oncology, Orphan and CNS/Pain/Addiction for small and medium-sized bio-pharma companies around the world. We work in these disease areas for two key reasons – professional therapeutic experience and personal passion. Our distinctive line of sight comes from the vantage point of our founders and our team having previously sat in the seats of our clients for decades. Our experts have spent much of their careers honing skills unique to bio-pharma such as Strategic Planning, Marketing, Market Access, Pricing, Medical Affairs, and Analytics. Each one of our client engagements is developed using Mirador Global’s proprietary Integration Methodology – addressing the single most significant gap in successfully creating and executing product launches. Bringing together Marketing, Medical Affairs, R&D and other functions in candid and constructive ways only possible with industry experts is what elevates our work to exceptional levels. We also offer clients the option of using our specialists for selective support to their commercial teams or to be their initial commercial teams before they are ready to internally hire. What We Do: • Global Commercial Strategy Development • US & Global Forecasting and Asset Valuation • Payer Reimbursement Risk Assessment & Mitigation • Portfolio Assessment and Prioritization • Commercial Road Map and Launch Planning